BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 34120320)

  • 1. Sec62 promotes pro-angiogenesis of hepatocellular carcinoma cells under hypoxia.
    Meng Y; Zhao H; Zhao Z; Yin Z; Chen Z; Du J
    Cell Biochem Biophys; 2021 Dec; 79(4):747-755. PubMed ID: 34120320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sec62 promotes early recurrence of hepatocellular carcinoma through activating integrinα/CAV1 signalling.
    Du J; Zhao Z; Zhao H; Liu D; Liu H; Chen J; Cheng B; Zhai X; Yin Z; Zhang Y; Ling C
    Oncogenesis; 2019 Dec; 8(12):74. PubMed ID: 31822656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
    Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
    Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIF-2alpha-dependent PAI-1 induction contributes to angiogenesis in hepatocellular carcinoma.
    Geis T; Döring C; Popp R; Grossmann N; Fleming I; Hansmann ML; Dehne N; Brüne B
    Exp Cell Res; 2015 Feb; 331(1):46-57. PubMed ID: 25489981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of cyclin B1 and Sec62 as biomarkers for recurrence in patients with HBV-related hepatocellular carcinoma after surgical resection.
    Weng L; Du J; Zhou Q; Cheng B; Li J; Zhang D; Ling C
    Mol Cancer; 2012 Jun; 11():39. PubMed ID: 22682366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
    Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
    Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
    [No Abstract]   [Full Text] [Related]  

  • 7.
    Casper M; Linxweiler M; Linxweiler J; Zimmermann R; Glanemann M; Lammert F; Weber SN
    Visc Med; 2021 Mar; 37(2):110-115. PubMed ID: 33977099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [LncRNA HULC promots HCC growth by downregulating miR-29].
    Zhu LR; Feng JL; Liu XJ; Wang JM
    Zhonghua Zhong Liu Za Zhi; 2019 Sep; 41(9):659-666. PubMed ID: 31550855
    [No Abstract]   [Full Text] [Related]  

  • 9. Overexpression of
    Bai L; Ren Y; Cui T
    J Comput Biol; 2020 Jun; 27(6):965-974. PubMed ID: 31593490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatics analysis of key genes and pathways for hepatocellular carcinoma transformed from cirrhosis.
    He B; Yin J; Gong S; Gu J; Xiao J; Shi W; Ding W; He Y
    Medicine (Baltimore); 2017 Jun; 96(25):e6938. PubMed ID: 28640074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics identification of crucial genes and pathways associated with hepatocellular carcinoma.
    Gao X; Wang X; Zhang S
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30341252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of key pathways in sorafenib-treated hepatocellular carcinoma based on a PCR-array.
    Liu Y; Wang P; Li S; Yin L; Shen H; Liu R
    Int J Clin Exp Pathol; 2015; 8(3):3027-35. PubMed ID: 26045814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uncovering potential key genes associated with the pathogenesis of asthma: A microarray analysis of asthma-relevant tissues.
    Guan Y; Jin X; Liu X; Huang Y; Wang M; Li X
    Allergol Immunopathol (Madr); 2017; 45(2):152-159. PubMed ID: 27842724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yes-associated protein (YAP) induces a secretome phenotype and transcriptionally regulates plasminogen activator Inhibitor-1 (PAI-1) expression in hepatocarcinogenesis.
    Marquard S; Thomann S; Weiler SME; Bissinger M; Lutz T; Sticht C; Tóth M; de la Torre C; Gretz N; Straub BK; Marquardt J; Schirmacher P; Breuhahn K
    Cell Commun Signal; 2020 Oct; 18(1):166. PubMed ID: 33097058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ribosomal protein S15a promotes tumor angiogenesis via enhancing Wnt/β-catenin-induced FGF18 expression in hepatocellular carcinoma.
    Guo P; Wang Y; Dai C; Tao C; Wu F; Xie X; Yu H; Zhu Q; Li J; Ye L; Yu F; Shan Y; Yu Z; Dhanasekaran R; Zheng R; Chen G
    Oncogene; 2018 Mar; 37(9):1220-1236. PubMed ID: 29242604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Characteristic genomics of peripheral blood mononuclear cells of hepatocellular carcinoma patients with liver-kidney yin deficiency syndrome].
    Weng L; Du J; He WT; Ling CQ
    Zhong Xi Yi Jie He Xue Bao; 2012 Apr; 10(4):406-15. PubMed ID: 22500714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and validation of three core genes in p53 signaling pathway in hepatitis B virus-related hepatocellular carcinoma.
    Yu M; Xu W; Jie Y; Pang J; Huang S; Cao J; Gong J; Li X; Chong Y
    World J Surg Oncol; 2021 Mar; 19(1):66. PubMed ID: 33685467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Screening core genes and cyclin B2 as a potential diagnosis, treatment and prognostic biomarker of hepatocellular carcinoma based on bioinformatics analysis].
    Yang SY; Ren H; Li CF; Tang H
    Zhonghua Gan Zang Bing Za Zhi; 2020 Sep; 28(9):773-783. PubMed ID: 33053978
    [No Abstract]   [Full Text] [Related]  

  • 20. Argonaute 2 promotes angiogenesis via the PTEN/VEGF signaling pathway in human hepatocellular carcinoma.
    Ye ZL; Huang Y; Li LF; Zhu HL; Gao HX; Liu H; Lv SQ; Xu ZH; Zheng LN; Liu T; Zhang JL; Jin HJ; Qian QJ
    Acta Pharmacol Sin; 2015 Oct; 36(10):1237-45. PubMed ID: 25937637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.